相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function
B. O. Khatri et al.
NEUROLOGY (2009)
Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy
Hans Linda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
CCL25 and CCL28 promote α4β7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow
Alice Miles et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
Brian G. Feagan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Role of β7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease
Maria Apostolaki et al.
GASTROENTEROLOGY (2008)
JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
J. Verbeeck et al.
GUT (2008)
Lymphocyte homing and its role in the pathogenesis of IBD
Bertus Eksteen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Leukocyte Adhesion Molecules in Animal Models of Inflammatory Bowel Disease
Jesus Rivera-Nieves et al.
INFLAMMATORY BOWEL DISEASES (2008)
The genetics and immunopathogenesis of inflammatory bowel disease
Judy H. Cho
NATURE REVIEWS IMMUNOLOGY (2008)
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
Brian G. Feagan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Efficacy of an inhibitor of adhesion molecule expression (GI270384X) in the treatment of experimental colitis
Julian Panes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Crohn's disease patients' risk-benefit preferences:: Serious adverse event risks versus treatment efficacy
F. Reed Johnson et al.
GASTROENTEROLOGY (2007)
Aberrant activation of integrin α4β7 suppresses lymphocyte migration to the gut
Eun Jeong Park et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Certolizumab pegol for the treatment of Crohn's disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
American Gastroenterological Association Consensus Development Conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006
M. Clark et al.
GASTROENTEROLOGY (2007)
Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial
William J. Sandborn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
Natalizumab for the treatment of active Crohn's disease: Results of the ENCORE trial
Stephan R. Targan et al.
GASTROENTEROLOGY (2007)
A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active Crohn's disease
Bruce Yacyshyn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy -: Possible interventions
Olaf Stuve et al.
ARCHIVES OF NEUROLOGY (2007)
Natalizumab therapy for moderate to severe Crohn disease in adolescents
Jeffrey S. Hyams et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab
Bruce E. Sands et al.
INFLAMMATORY BOWEL DISEASES (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Antisense therapy of MAdCAM-1 for trinitrobenzenesulfonic acid-induced murine colitis
Akira Goto et al.
INFLAMMATORY BOWEL DISEASES (2006)
Synthesis and biological evaluation of novel pyridazinone-based α4 integrin receptor antagonists
Yong Gong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A Phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis
SJH Van Deventer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis
PB Miner
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Crohn's disease:: increased mortality 10 years after diagnosis in a Europe-wide population based cohort
FL Wolters et al.
GUT (2006)
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
TA Yousry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
Blocking MAdCAM-1 in vivo reduces leukocyte extravasation and reverses chronic inflammation in experimental colitis
S Farkas et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2006)
Natalizumab induction and maintenance therapy for Crohn's disease
WJ Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis
T Bernklev et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Targeting leukocyte integrins in human diseases
K Yonekawa et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases - I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease
G Van Assche et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery
J Cosnes et al.
GUT (2005)
Blocking lymphotoxin-β receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis
P Stopfer et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40
WA Knowles et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Comparison of cell culture-grown JC virus (primary human fetal glial cells and the JCI cell line) and recombinant JCV VP1 as antigen for the detection of anti-JCV antibody by haemagglutination inhibition
WA Knowles et al.
JOURNAL OF VIROLOGICAL METHODS (2003)
Natalizumab for active Crohn's disease.
S Ghosh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS
SM Richardson-Burns et al.
ARCHIVES OF NEUROLOGY (2002)
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease
BR Yacyshyn et al.
GUT (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behavior
ZQ Li et al.
JOURNAL OF CELL BIOLOGY (2002)
Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination
MA Moscarello et al.
MULTIPLE SCLEROSIS JOURNAL (2002)
The lymphocyte metalloprotease MDC-L (ADAM 28) is a ligand for the integrin α4β1
LC Bridges et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice
RC Burns et al.
GASTROENTEROLOGY (2001)
A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active Crohn's disease
FH Gordon et al.
GASTROENTEROLOGY (2001)
Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease
S Schreiber et al.
GASTROENTEROLOGY (2001)
Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon α4β1-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin
VP Yakubenko et al.
EXPERIMENTAL CELL RESEARCH (2000)
Advances in immunology: T-cell function and migration - Two sides of the same coin
UH von Andrian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice
A Soriano et al.
LABORATORY INVESTIGATION (2000)
An ascending dose trial of a humanized A4B7 antibody in ulcerative colitis (UC).
BG Feagan et al.
GASTROENTEROLOGY (2000)
分享论文
